Robust Approach to Combining Multiple Markers to Improve Surrogacy
From MaRDI portal
Publication:6079767
DOI10.1111/biom.13677zbMath1522.62253OpenAlexW4224080885MaRDI QIDQ6079767
Tianxi Cai, Xu An Wang, Layla Parast, L. Tian, Unnamed Author
Publication date: 30 October 2023
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347081
Cites Work
- Unnamed Item
- Efficiency improvement in a class of survival models through model-free covariate incorporation
- The evaluation of surrogate endpoints.
- Surrogate Measures and Consistent Surrogates
- Comparing Biomarkers as Principal Surrogate Endpoints
- The Evaluation of Multiple Surrogate Endpoints
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial
- Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
- Related Causal Frameworks for Surrogate Outcomes
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
- Regression Modeling of Competing Risks Data Based on Pseudovalues of the Cumulative Incidence Function
- Evaluating multiple surrogate markers with censored data
This page was built for publication: Robust Approach to Combining Multiple Markers to Improve Surrogacy